Client News

Spexis provides business update and announces financial results for the first half of 2022

ABIVAX PUBLISHES A PROSPECTUS IN THE CONTEXT OF ITS CAPITAL INCREASE

ABIVAX ANNOUNCES SUCCESSFUL OVERSUBSCRIBED EUR 49.2M CROSS-OVER FINANCING WITH TOP-TIER US AND EUROPEAN BIOTECH INVESTORS

AiCuris appoints experienced business leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer

Carbios strengthens Executive Committee with the appointment of Pascal Bricout as Chief Strategy & Financial Officer

Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication

Spexis announces presentation of half-year 2022 financial results and participation at upcoming industry and investor events in September

Carbios’ Chief Scientific Officer Alain Marty Receives the Prestigious Biocat Award

Marinomed Biotech AG continues its growth path and reports strong financials in H1 2022

Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility